Enterobacter sakazakiicase reports and outbreaks involving infants as reported in the peer-reviewed English literature |
Karl Klontz[17] |
|
Formula associated infectionEnterobacter sakazakiiand Salmonella - Recent CDC experience |
Chris Braden |
|
Industry practices and standards: The management of Salmonella and Enterobacteriaceae |
Jean-Louis Cordier |
|
Thermal resistance and other characteristics of Enterobacter sakazakii |
Robert Buchanan |
|
Proposed draft revision of the recommended international code of hygienic practice for foods for infants and children |
Jeffrey Farber |
|
Canadian situation and approaches to addressing the issues related to powdered infant formula |
Jeffrey Farber |
|
Powdered infant formula industry practices and standards in the United States of America |
Daniel March |
|
Marketing and preparation of powdered infant formula |
Hildegard Przyrembel |
|
Practical considerations for risk based calculations for powdered infant formula |
Marcel Zwietering |
|
Risk assessment of Enterobacter sakazakiiand Salmonellain powdered infant formula: a discussion document |
Prepared by Arie Havelaar[18] |
|
Enterobacter sakazakii in Israel: Summary |
Colin Block |
|
Overview of powdered infant formula production, consumption, microbiological data and associated public health problems in the Philippines |
Celia Carlos |
|
Bacterial contamination of infant food formula in Bangladesh and the region |
G. Balakrish Nair |
|
Neonatal infections due to Enterobacter sakazakiiin the Netherlands, 1975-2002 |
Harry Muytjens |
|
Microbiological safety of infant formula and related dairy ingredients: summary of information from Australia |
Martin Cole |
|
Overview of powdered infant formula production, consumption, criteria, microbiological data and associated public health problems in Japan |
Shizunobu Igimi |
[17] Video
presentation. [18] Convened an electronic discussion group that addressed risk assessment approaches but unavailable to participate in the meeting. |